Updated: Dec 23, 2020
Gainesville, FL – November 10, 2020
Evren was notified today that its Mark PHOENIX had been issued a U.S. Trademark Registration covering medical devices for delivering neuro-stimulation and neuromodulation for treating psychological and neuropsychological disorders, including PTSD and other indications.
“We are delighted that our Phoenix® Mark has finally made it through the registration process in the United States. There are pending applications for the Phoenix in several international locations as well,” said Blythe Karow, President & CEO of Evren Technologies, “We chose the name Phoenix® for our PTSD treatment as it gives the connotation of a thing of beauty being reborn from a tragic situation, which is how we hope our customers will feel when using the Phoenix® to treat their PTSD.”
About Evren Technologies
Evren Technologies is a development stage bioelectronic medicine company at the forefront of two of the most rapidly-growing spaces in the medical device industry: Vagal Nerve Stimulation (VNS), and wearable tech. We are bringing cutting-edge VNS technology to a user-friendly and intelligent hardware and software platform that is easy to use and personalized. Our initial product - the Phoenix® - delivers transcutaneous auricular vagal nerve stimulation in a discreet earbud design for the treatment of Post-Traumatic Stress Disorder (PTSD).
M. Blythe Karow
President and CEO
Evren Technologies, Inc.